Aletheian Wealth Advisors LLC Abb Vie Inc. Transaction History
Aletheian Wealth Advisors LLC
- $195 Million
- Q2 2025
A detailed history of Aletheian Wealth Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Aletheian Wealth Advisors LLC holds 1,855 shares of ABBV stock, worth $351,170. This represents 0.18% of its overall portfolio holdings.
Number of Shares
1,855
Previous 2,092
11.33%
Holding current value
$351,170
Previous $438,000
21.46%
% of portfolio
0.18%
Previous 0.26%
Shares
8 transactions
Others Institutions Holding ABBV
# of Institutions
4,253Shares Held
1.27BCall Options Held
16.5MPut Options Held
14.9M-
Vanguard Group Inc Valley Forge, PA174MShares$32.9 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.8 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15.1 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.4 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.79 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $335B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...